Skip to main content
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

  • Register
  • Log in
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
  • AACR Publications
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in

Search

  • Advanced search
Cancer Research
Cancer Research

Advanced Search

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • Focus on Computer Resources
    • 75th Anniversary
    • Meeting Abstracts
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • OnlineFirst
    • Editors' Picks
    • Citations
    • Author/Keyword
  • News
    • Cancer Discovery News
Molecular and Cellular Biology, Genetics

Abstract 2886: KLF8 phosphorylation at Serine 48 by ERK2 is critical for its stability and function

Satadru Lahiri, Heng Lu, Debarati Mukherjee, Lin Yu and Jihe Zhao
Satadru Lahiri
University of Central Florida, Orlando, FL.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Heng Lu
University of Central Florida, Orlando, FL.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Debarati Mukherjee
University of Central Florida, Orlando, FL.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lin Yu
University of Central Florida, Orlando, FL.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jihe Zhao
University of Central Florida, Orlando, FL.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1538-7445.AM2016-2886 Published July 2016
  • Article
  • Info & Metrics
Loading
Proceedings: AACR 107th Annual Meeting 2016; April 16-20, 2016; New Orleans, LA

Abstract

Krüppel-like factor 8 (KLF8) is a member of Krüppel like family transcription factor which was found to be upregulated in different types of cancers, primarily breast and ovarian cancer. It transcriptionally activates a host of downstream effectors like CyclinD1, EGFR, MMP9, and EPSTI1 to promote cell proliferation, cancer cell invasion and migration. Additionally, KLF8 transcriptionally represses E-cadherin to induce epithelial to mesenchymal transition and oncogenic transformation of cell. As such, KLF8 plays a central role in cancer progression. Several types of post-translational modifications including sumoylation, acetylation, ubiquitylation and PARylation have been discovered that regulate KLF8's function KLF8 has been shown to consistently migrate as doublet on SDS-PAGE. However, the reason for this motility shift of KLF8 has remained mysterious. We performed a series of experiments to determine the mechanism(s) behind this motility shift of KLF8. Truncation mutation showed that deletion of the first 50 amino acid residues, but not other regions, caused disappearance of the top band of the doublet, suggesting that the N50 region is responsible for the motility shift. Phosphatase treatment resulted in the same change in wild-type KLF8 protein, indicating that phosphorylation in the N50 region is causal to the motility shift. Further deletion and point mutation in this region identified Serine 48 as a novel phosphorylation site for KLF8. Interestingly, these experiments also identified KLF8 N terminal 31-40 region to play an important role in regulating the S48 phosphorylation and the motility shift. Our study identified that phosphorylation at Serine 48 is critical in maintaining KLF8 stability. Finally, we demonstrated that abolishing KLF8 S48 phosphorylation inhibits KLF8 mediated cancer cell migration. Kinase inhibitors treatment showed that ERK2 is the kinase responsible for KLF8 Serine 48 phosphorylation. Furthermore we identified that phosphorylated KLF8 acts as a mask to protect unphosphorylated KLF8. Overall this study identifies a novel phosphorylation site of KLF8 and a hitherto unknown link between ERK2 and KLF8 that is critical for maintaining its overall stability and function.

Citation Format: Satadru Lahiri, Heng Lu, Debarati Mukherjee, Lin Yu, Jihe Zhao. KLF8 phosphorylation at Serine 48 by ERK2 is critical for its stability and function. [abstract]. In: Proceedings of the 107th Annual Meeting of the American Association for Cancer Research; 2016 Apr 16-20; New Orleans, LA. Philadelphia (PA): AACR; Cancer Res 2016;76(14 Suppl):Abstract nr 2886.

  • ©2016 American Association for Cancer Research.
Previous
Back to top
Cancer Research: 76 (14 Supplement)
July 2016
Volume 76, Issue 14 Supplement
  • Table of Contents
  • Index by Author

Sign up for alerts

Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Abstract 2886: KLF8 phosphorylation at Serine 48 by ERK2 is critical for its stability and function
(Your Name) has forwarded a page to you from Cancer Research
(Your Name) thought you would be interested in this article in Cancer Research.
Citation Tools
Abstract 2886: KLF8 phosphorylation at Serine 48 by ERK2 is critical for its stability and function
Satadru Lahiri, Heng Lu, Debarati Mukherjee, Lin Yu and Jihe Zhao
Cancer Res July 15 2016 (76) (14 Supplement) 2886; DOI: 10.1158/1538-7445.AM2016-2886

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Abstract 2886: KLF8 phosphorylation at Serine 48 by ERK2 is critical for its stability and function
Satadru Lahiri, Heng Lu, Debarati Mukherjee, Lin Yu and Jihe Zhao
Cancer Res July 15 2016 (76) (14 Supplement) 2886; DOI: 10.1158/1538-7445.AM2016-2886
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics
Advertisement

Related Articles

Cited By...

More in this TOC Section

Molecular and Cellular Biology, Genetics

  • Abstract LB-336: Specific serine phosphorylation of IRE-1 controls enhanced splicing of XBP-1 and regulated IRE-1-dependent decay (RIDD)
  • Abstract LB-276: Characterizing tumorigenesis of ovarian cancer across metastatic tumors and circulating, cell-free DNA
  • Abstract LB-335: Induction of Ribosomal Checkpoint Induced Senescence (RCIS) for the treatment of liver cancer
Show more 3

Poster Presentations - Proffered Abstracts

  • Abstract LB-236: Risk of tMDS/AML after chemotherapy for first primary lymphoid malignancy, 2000-2013
  • Abstract LB-001: Impact of direct physician engagement with racial/ethnic minorities for oncology clinical trial access and accrual model
  • Abstract LB-107: EV-TRACK: transparent reporting and centralizing knowledge of extracellular vesicles to support the validation of extracellular vesicle biomarkers in cancer research
Show more 3

Poster Presentations - Transcriptional Regulation and Gene Expression in Human Malignancies

  • Abstract 2891: High throughput single cell gene expression profiling by multiplex qPCR
  • Abstract 2889: Loss of 4E-BP1 function promotes EMT and metastasis via translational activation of snail
  • Abstract 2868: Mechanisms of transcriptional regulation of FOXO3 by cofactors upon PI3K/AKT/mTOR inhibition
Show more 3
  • Home
  • Alerts
  • Feedback
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians
  • Reviewers

About Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2018 by the American Association for Cancer Research.

Cancer Research Online ISSN: 1538-7445
Cancer Research Print ISSN: 0008-5472
Journal of Cancer Research ISSN: 0099-7013
American Journal of Cancer ISSN: 0099-7374

Advertisement